Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cilo Cybin HoldingsJSE:CCC 7 Days Payable is 41.39 as of Sep. 2025. GuruFocus rates JSE:CCC with a GF Score™ of 7/100. The stock has 1 warning sign investors should review. Among 927 Drug Manufacturers companies, Cilo Cybin Holdings ranks worse than 70.98% on this metric.
The historical rank and industry rank for Cilo Cybin Holdings's Days Payable or its related term are showing as below:
JSE:CCC'
s Days Payable Range Over the Past 10 Years
Min: 0 Med: 0 Max: 55.32
Current: 55.32
During the past 4 years, Cilo Cybin Holdings's highest Days Payable was 55.32. The lowest was 0.00. And the median was 0.00.
JSE:CCC's Days Payable is ranked worse than 70.98% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.28
vs JSE:CCC: 55.32
Cilo Cybin Holdings's Days Payable
increased
from Sep. 2024 (0.00) to Sep. 2025 (41.39).
It may suggest that Cilo Cybin Holdingsdelayed paying its suppliers.
The historical data trend for Cilo Cybin Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:CCC vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cilo Cybin Holdings Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Cilo Cybin Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cilo Cybin Holdings's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cilo Cybin Holdings (JSE:CCC) has a Days Payable of 41.39 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cilo Cybin Holdings and its competitors. According to the industry distribution chart, Cilo Cybin Holdings ranks #658 out of 927 companies in the Drug Manufacturers industry, placing it in the top 71%.
Is Cilo Cybin Holdings' Days Payable too high?
Cilo Cybin Holdings' current Days Payable is 41.39. The Drug Manufacturers industry median Days Payable is 90.28. Cilo Cybin Holdings' value of 41.39 is 54.2% below this industry median. Based on the distribution chart, Cilo Cybin Holdings ranks #658 out of 927 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cilo Cybin Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Cilo Cybin Holdings' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cilo Cybin Holdings ranks #658 out of 927 companies for Days Payable. This places Cilo Cybin Holdings in the lower half of its industry. The industry median Days Payable is 90.28. Cilo Cybin Holdings' value of 41.39 is 54.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.28, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cilo Cybin Holdings's current Days Payable of 41.39 is 54.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cilo Cybin Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cilo Cybin Holdings's current Days Payable is 41.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cilo Cybin Holdings stock overvalued right now?
Cilo Cybin Holdings (JSE:CCC) has a current Days Payable of 41.39. The current Days Payable is 41.39 and 54.2% below the Drug Manufacturers industry median of 90.28. Cilo Cybin Holdings' overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cilo Cybin Holdings (JSE:CCC), the current Days Payable is 41.39 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cilo Cybin Holdings Ltd is engaged in identifying viable investments in Biotech, Biohacking and Pharmaceutical businesses. It offers products and services in the medical cannabis sector.
7GF Score
Get the complete analysis for JSE:CCC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:CCC has been successfully added to your 
